BellSouth Telecommunications, Inc. v. Harris

174 So. 3d 909, 2015 Miss. App. LEXIS 272, 2015 WL 3544434
CourtCourt of Appeals of Mississippi
DecidedMay 19, 2015
DocketNo. 2012-WC-01975-COA
StatusPublished
Cited by1 cases

This text of 174 So. 3d 909 (BellSouth Telecommunications, Inc. v. Harris) is published on Counsel Stack Legal Research, covering Court of Appeals of Mississippi primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
BellSouth Telecommunications, Inc. v. Harris, 174 So. 3d 909, 2015 Miss. App. LEXIS 272, 2015 WL 3544434 (Mich. Ct. App. 2015).

Opinion

JAMES, J.,

for the Court:

¶ 1. This appeal proceeds from a Mississippi Workers’ Compensation Commission order granting a claimant’s motion to compel payment of medical treatment relating to a kidney condition caused by medication taken for an admittedly compensable lung injury. Finding no error, we affirm.

FACTS AND PROCEDURAL HISTORY

¶2. On October 6, 1997, the claimant, Larry B. Harris, inhaled materials under a building while installing cables in the course of his employment with BellSouth Telecommunications Inc. (BellSouth). BellSouth provided compensation benefits to Harris for the pulmonary (lung) condition caused by the inhalation. Nevertheless, on December 12, 2000, Harris filed a petition to controvert, and a full hearing on the merits was conducted on February 20, 2009, before an administrative judge (AJ).

¶3. The parties stipulated that Harris, acting in the course and scope of his employment with BellSouth on October 6, 1997, was involved in a work-related incident, which ultimately resulted in a respiratory condition. Remaining issues to be decided were: (1) the existence/extent of temporary disability, if any; (2) existence/extent of permanent disability and/or loss of wage-earning capacity, if any; and (3) reasonableness/necessity of certain medical treatment. On September 10, 2009, the AJ entered an order finding that Harris suffered no permanent disability and/or loss of wage-earning capacity from his respiratory-inhalation injury and was not entitled to additional temporary disability benefits.

¶4. On March 1, 2010, the Commission amended the AJ’s order and found that Harris was entitled to permanent partial disability benefits. The Commission also ordered BellSouth and its carrier to continue to provide and pay for all reasonable and necessary medical services and treatment in accordance with Mississippi Code Annotated section 71-3-15 (Supp.2014). BellSouth did not appeal the Commission’s decision and provided compensation benefits to Harris.

¶ 5. During the course of Harris’s treatment for his compensable lung injury, he was prescribed certain medications, including amphotericin B. Dr. Murphy S. Martin, a nephrologist and treating physician, opined that the amphotericin B caused complications with Harris’s kidney, which required kidney medication. Harris requested medical payments from BellSouth’s carrier for the medication prescribed for Harris’s renal (kidney) insufficiency diagnosed by Dr. Martin. However, BellSouth’s carrier denied payment despite Harris’s insistence that his [911]*911renal insufficiency was causally related to his lung injury.

¶ 6. On November 7, 2011, BellSouth filed a motion for an employer’s medical examination (EME) to be performed by Dr. Wilson Parry under Mississippi Code Annotated section 71-3-15. On December 19, 2011, Harris filed a motion to compel payment of certain medical treatment and response to BellSouth’s motion for an EME. A hearing was conducted before the AJ on the competing motions. On April 16, 2012, the AJ ordered BellSouth and its carrier to provide all medical benefits regarding Harris’s treatment, including medication as opined by Dr. Martin to be related to his initial lung injury at work.

¶ 7. BellSouth filed a petition for review. The sole issue on review was the causal relationship of Harris’s kidney and other problems to his initial work-related lung injury. More than a month after the AJ ruled in Harris’s favor, BellSouth gave notice on May 22, 2012, that it retained Dr. Parry to review Harris’s medical records and give an opinion on the central question of causation, even though the record had been closed. A hearing before the Commission was held on July 16, 2012.

¶ 8. Following the hearing, on October 18, 2012, BellSouth submitted a supplementation to its brief of law and fact containing Dr. Parry’s opinion as additional evidence to be considered. Dr. Parry concluded that the medication did not cause or had very little impact on Harris’s renal insufficiency. Harris filed a motion to strike the supplementation, which was granted by the Commission, and it was given no consideration whatsoever because it was untimely under Mississippi Workers’ Compensation Procedural Rule 9.

¶ 9. On November 16, 2012, the Commission affirmed the AJ’s order granting Harris’s motion to compel payment of medical treatment. The Commission considered the opinions and observations of several physicians in arriving at its decision, including Dr. Martin, a nephrologist specializing in the treatment of kidney diseases and disorders. On February 25, 2011, Dr. Martin stated:

Mr. Harris is being treated by me for stage III chronic kidney disease. This is caused by prior amphotericin B therapy for aspergillus contracted while he was at work. He had amphotericin induced renal failure with [the] biopsy showing secondary focal segmental glomerulosclerosis. He also received prednisone therapy because of the lung disease that resulted in diabetes that persists to this day. It is my opinion that all of his therapy at this time for his hypertension, chronic kidney disease, secondary hyperparathyroidism and vitamin D deficiency, lung disease, and diabetes is a result of his aspergillosis infection contracted while at work.

¶ 10. The Commission also considered the conclusions reached by Dr. William Causey, an infectious-disease specialist who treated Harris in 1998. Dr. Causey noted: “[Harris] has slightly low potassium and slightly elevated creatinine[,] which I believe are residual effects of the amphotericin that he received for his pulmonary aspergillosis back in late 1997.” Dr. Causey also noted that Harris’s laboratory abnormalities “probably reflect residual [a]mphotericin B effects.” Dr. Obie McNair, a treating physician during Harris’s hospital stay in 1998, noted that Harris’s initial medical treatment was having a negative effect on his kidneys and acknowledged his low potassium and abnormal creatinine readings while undergoing amphotericin B therapy.

¶ 11. Dr. Douglas Campbell of the University of Mississippi Medical Center (UMMC), a specialist in the pulmonary clinic, noted on September 25, 2005, that [912]*912Harris was referred to a nephrologist because of his increased creatinine, which he thought might be due to amphotericin B treatment. Dr. John R. Spurzem, professor of medicine in the pulmonary, critical-care and sleep-medicine division at UMMC, stated on September 8, 2010, that “[s]ubsequeht physicians have assumed that his mild chronic renal insufficiency has been related to the [ajmphotericin, and I have no reason to think otherwise.”

¶ 12. The Commission’s order provided in pertinent part:

The [AJ] considered and weighted a significant amount of medical evidence concerning the potential complications which can arise from the use of [ampho-tericin B, which was given to Mr. Harris in 1997 and 1998 following his lung injury in late 1997. We find more than enough credible evidence linking Mr. Harris’s current renal and other problems to the use of the medicine. The opinions of all the different physicians involved are not unanimous, but the greater weight of their testimony support[s] the causative link found by the [AJ] and by us.

It is from this order of the Commission that BellSouth appeals to this Court. Findingno error, we affirm the decision of the Commission.

STANDARD OF REVIEW

¶ 13.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Prairie Farms Dairy v. Gregory Graham
270 So. 3d 37 (Court of Appeals of Mississippi, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
174 So. 3d 909, 2015 Miss. App. LEXIS 272, 2015 WL 3544434, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bellsouth-telecommunications-inc-v-harris-missctapp-2015.